Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00404365 · ClinicalTrials.gov registry record · NA
Depression Screening in Patients With Lung Cancer
A NA study, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 241
- Enrollment target
NCT00404365: Completed NA study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00404365 is a NA study that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 241 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00404365, a NA study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 241 participants
- Enrollment target
Study Summary
RATIONALE: Screening tests may help doctors find depression in patients with lung cancer, allow doctors to recommend treatment for depression, and improve the patient's quality of life. PURPOSE: This randomized clinical trial is studying how well depression screening works when the results are or are not shared with patients with lung cancer and their doctor.
Interventions
- OTHER screening questionnaire administration
- OTHER counseling intervention
- OTHER study of socioeconomic and demographic variables
- PROCEDURE psychosocial assessment and care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 241 participants |
| Start Date | 2006-04 |
| Est. Completion | 2012-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00404365
The ClinicalTrials.gov registry entry for NCT00404365 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 241 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which screening questionnaire administration is the first listed.
NCT00404365 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00404365 about?
NCT00404365 is a clinical study titled "Depression Screening in Patients With Lung Cancer". RATIONALE: Screening tests may help doctors find depression in patients with lung cancer, allow doctors to recommend treatment for depression, and improve the patient's quality of life. PURPOSE: This randomized clinical trial is studying how well depression screening works when the results are or a...
What is the current status of trial NCT00404365?
This trial is currently completed. It is a NA study. The enrollment target is 241 participants. The study started on 2006-04. Estimated completion is 2012-04.
What interventions are being tested in trial NCT00404365?
The interventions under investigation include: screening questionnaire administration (OTHER), counseling intervention (OTHER), study of socioeconomic and demographic variables (OTHER), psychosocial assessment and care (PROCEDURE).
Who is sponsoring clinical trial NCT00404365?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.